DiDomenico, J., Veliceasa, D., Choy, W., Oyon, D., Lamano, J., Lamano, J., . . . Bloch, O. (2017). IMMU-13. PD-L1 EXPRESSION PREDICTS SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING VACCINE IMMUNOTHERAPY BUT NOT STANDARD THERAPY ALONE. Neuro Oncol.
Chicago Style CitationDiDomenico, Joseph, Dorina Veliceasa, Winward Choy, Daniel Oyon, Jonathan Lamano, Jason Lamano, Leonel Ampie, Andrew Parsa, i Orin Bloch. "IMMU-13. PD-L1 EXPRESSION PREDICTS SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING VACCINE IMMUNOTHERAPY BUT NOT STANDARD THERAPY ALONE." Neuro Oncol 2017.
Cita MLADiDomenico, Joseph, et al. "IMMU-13. PD-L1 EXPRESSION PREDICTS SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING VACCINE IMMUNOTHERAPY BUT NOT STANDARD THERAPY ALONE." Neuro Oncol 2017.